Theriva Biologics Inc. (TOVX) — Cash Flow-to-Debt Ratio
Theriva Biologics Inc. (TOVX) has a Cash Flow-to-Debt Ratio of -0.11x as of March 2026, meaning its operating cash flow of $-2.46 Million could theoretically repay 0% of its total liabilities ($22.85 Million) in one year. See TOVX FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Theriva Biologics Inc. Cash Flow-to-Debt Ratio (1993–2025)
Historical debt coverage capacity for Theriva Biologics Inc. across 31 annual periods. For the full cash flow conversion analysis, see Theriva Biologics Inc. cash conversion from operations.
Annual Cash Flow-to-Debt Ratio for Theriva Biologics Inc. (1993–2025)
Year-by-year debt coverage analysis for Theriva Biologics Inc.. Check how high is Theriva Biologics Inc.'s earnings quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.73x | $-16.67 Million | $22.86 Million | ▲ +29.9% |
| 2024 | -1.04x | $-16.94 Million | $16.29 Million | ▲ +15.0% |
| 2023 | -1.22x | $-19.00 Million | $15.52 Million | ▼ -10.9% |
| 2022 | -1.10x | $-19.08 Million | $17.30 Million | ▲ +57.6% |
| 2021 | -2.60x | $-12.89 Million | $4.96 Million | ▲ +32.6% |
| 2020 | -3.86x | $-12.17 Million | $3.15 Million | ▼ -59.9% |
| 2019 | -2.41x | $-13.87 Million | $5.75 Million | ▲ +48.5% |
| 2018 | -4.69x | $-17.28 Million | $3.69 Million | ▼ -416.2% |
| 2017 | -0.91x | $-20.20 Million | $22.25 Million | ▲ +34.1% |
| 2016 | -1.38x | $-27.90 Million | $20.25 Million | ▲ +43.9% |
| 2015 | -2.45x | $-38.89 Million | $15.84 Million | ▼ -46.4% |
| 2014 | -1.68x | $-16.08 Million | $9.59 Million | ▲ +77.7% |
| 2013 | -7.52x | $-7.72 Million | $1.03 Million | ▲ +66.7% |
| 2012 | -22.57x | $-8.92 Million | $395.00K | ▼ -227.4% |
| 2011 | -6.89x | $-2.88 Million | $417.00K | ▼ -222.1% |
| 2010 | -2.14x | $-1.14 Million | $532.48K | ▲ +61.0% |
| 2009 | -5.49x | $-2.92 Million | $531.43K | ▲ +29.7% |
| 2008 | -7.82x | $-4.85 Million | $620.72K | ▼ -99.6% |
| 2007 | -3.92x | $-6.61 Million | $1.69 Million | ▼ -20.6% |
| 2006 | -3.25x | $-2.37 Million | $729.02K | ▼ -542.9% |
| 2005 | -0.50x | $-1.08 Million | $2.14 Million | ▼ -46.5% |
| 2002 | -0.34x | $-5.82 Million | $16.90 Million | ▲ +52.4% |
| 2001 | -0.72x | $-8.07 Million | $11.14 Million | ▲ +24.8% |
| 2000 | -0.96x | $-5.65 Million | $5.86 Million | ▲ +73.9% |
| 1999 | -3.69x | $-16.14 Million | $4.38 Million | ▲ +56.6% |
| 1998 | -8.50x | $-18.70 Million | $2.20 Million | ▼ -267.9% |
| 1997 | -2.31x | $-6.70 Million | $2.90 Million | ▲ +57.6% |
| 1996 | -5.45x | $-6.00 Million | $1.10 Million | ▲ +70.9% |
| 1995 | -18.75x | $-7.50 Million | $400.00K | ▼ -275.0% |
| 1994 | -5.00x | $-4.50 Million | $900.00K | ▲ +71.4% |
| 1993 | -17.50x | $-3.50 Million | $200.00K | — |